Biodroga Inc. and Gelcell Sign Marketing Alliance to Promote Softgels Made with Animal-free Gelatin

Gelcell, A Division of Global Encapsulation (Windsor, ON) and Biodroga
Inc. (Vaudreuil-Dorion, QC) jointly announce an alliance to promote
Biodroga's customized formulations of their proprietary essential fatty
acids(EFA) in Gelcell's C-Caps™, the first commercially-viable softgels
containing animal-free gelatin featuring SeaGel® (patent pending)from
FMC Biopolymer.

Citing Gelcell's commitment to service, quality, and technology
advancements, Mr. Peter Houghton, General Manager of Biodroga explains
that the culture of the two companies are very similar and made the
decision to work together on this project very easy. "We have been
working with Gelcell for several years and have witnessed their
transformation from a small commodity-producer of softgels to a
technically advanced and customer-focused leader in the industry. CCaps
™ will allow us to fill a growing consumer need for softgels with a
gelatin derived from non-animal sources. ", explains Houghton.

"Biodroga continues to lead the nutraceutical market with innovative
and effective products", denotes Michael Ratko, President of Gelcell.
He adds, "Biodroga is always one step ahead in the essential fatty acid
(EFA) segment and is poised to secure their lead with C-Caps(tm)."
For more information on Biodroga's innovative formulations in CCaps(
tm), contact Fred Bernier or Vince Cascella at 1-800-371-9668 or
via email at [email protected]. (

C-Caps(tm) is a trademark of Gelcell, A Division of Global
Encapsulation Inc., Windsor, ON. For more info contact Florin Barbu at
519.254.4800 or via email at [email protected]
( C-Caps(tm) utilize SeaGel® (patent pending)
from FMC Corp., Philadelphia, PA. (

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.